Drug Profile
Streptococcal A vaccine - Active Biotech
Latest Information Update: 26 Jan 2017
Price :
$50
*
At a glance
- Originator Active Biotech
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 25 Jan 2017 Discontinued - Preclinical for Streptococcal infections in Sweden (Parenteral)
- 01 Jul 2002 Streptococcus A vaccine is due to be licensed out to a collaboration partner during 2002
- 14 Dec 2000 Actinova has been closed down